
SR 2640 hydrochloride
CAS No. 146662-42-2
SR 2640 hydrochloride( —— )
Catalog No. M33931 CAS No. 146662-42-2
SR 2640 hydrochloride is a competitive antagonist of leukotriene D4 and E4 and can be used in studies about leukotrienes in human asthma.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 62 | Get Quote |
![]() ![]() |
5MG | 92 | Get Quote |
![]() ![]() |
10MG | 140 | Get Quote |
![]() ![]() |
25MG | 273 | Get Quote |
![]() ![]() |
50MG | 440 | Get Quote |
![]() ![]() |
100MG | 620 | Get Quote |
![]() ![]() |
500MG | 1332 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSR 2640 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionSR 2640 hydrochloride is a competitive antagonist of leukotriene D4 and E4 and can be used in studies about leukotrienes in human asthma.
-
DescriptionSR2640 (hydrochloride) is a potent and selective competitive leukotriene D4/leukotriene E4 antagonist. SR2640 can be used for researching the role of leukotrienes in human asthma.
-
In Vitro——
-
In VivoSR2640 inhibits the LTD 4-induced contractions of guinea-pig ileum in a concentration-dependent manner, with an IC50 of 3 nM.SR2640 (1 mg/kg; IV; single dosage) specifically prevents the contractile responses of guinea-pig ileum and trachea to LTD4 and LTE4.Animal Model:Guinea pigs (injected with LTD4 and LTE4)Dosage:1 mg/kg Administration:IV; single dosage Result:Specifically prevented the contractile responses of guinea-pig ileum and trachea to LTD4 and LTE4.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetLeukotriene Receptor
-
RecptorLeukotriene Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number146662-42-2
-
Formula Weight406.86
-
Molecular FormulaC23H19ClN2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (614.46 mM; Ultrasonic )
-
SMILESCl.OC(=O)c1ccccc1Nc1cccc(OCc2ccc3ccccc3n2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ahnfelt-R?nne I, Kirstein D, Kaergaard-Nielsen C. A novel leukotriene D4/E4 antagonist, SR2640 (2-[3-(2-quinolylmethoxy)phenylamino]benzoic acid). Eur J Pharmacol. 1988;155(1-2):117-128.?
molnova catalog



related products
-
Ablukast
Ablukast is a leuktriene receptor antagonist. Ablukast acts as an anti-asthmatic.
-
Montelukast sodium
Montelukast sodium (MK0476, MK-0476) is a potent, selective, orally active leukotriene D4 receptor (LTD4) antagonist with Ki of 0.18 nM for guinea pig lung LTD4.
-
Amelubant
Amelubant (BIIL284) is a potent, long-acting, orally active leukotriene B4 (LTB4) receptor antagonist.